# Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

> **NCT03860961** · NA · COMPLETED · sponsor: **NRG Oncology** · enrollment: 550 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **OTHER:** Survivorship Care Plan
- **OTHER:** Treatment Plan

## Key facts

- **NCT ID:** NCT03860961
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-26
- **Primary completion:** 2024-11-14
- **Final completion:** 2025-09-04
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2025-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03860961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03860961, "Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT03860961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*